Product Comparison


 

No Image

Seqirus USA Inc 70461042110
Seqirus USA Inc 70461032103
Grifols Therapeutics 13533013101
Seqirus USA Inc 70461012103
McKesson # 654966 1183068 1183069 981867 1183071
Description PAPER,92 BRITE 20#,WE Flucelvax® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 2 Years of Age and Above Multiple Dose Vial 5 mL Flucelvax® Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 2 Years of Age and Above Prefilled Syringe 0.5 mL Td Vaccine 7 Years of Age and Older Tetanus and Diphtheria Toxoids Adsorbed Injection Single Dose Vial 0.5 mL FLUAD™ 2021 - 2022 Flu Vaccine, Adjuvanted 45 mcg / 0.5 mL Indicated For People 65 Years of Age and Above Prefilled Syringe 0.5 mL
Manufacturer # CAS-OX9001JR70461042110704610321031353301310170461012103
Brand  Flucelvax® Quadrivalent 2021 - 2022Flucelvax® Quadrivalent 2021 - 2022 FLUAD™ 2021 - 2022
Manufacturer United Stationers Supply CoSeqirus USA IncSeqirus USA IncGrifols TherapeuticsSeqirus USA Inc
Invoice PAPER,92 BRITE 20#,WEFLUCELVAX 2021, QUAD MDV 5ML (10DOSE/VL)FLUCELVAX 2021, QUAD SYR 0.5ML(10DOSE/BX)TDVAX, SDV 0.5ML (10/PK)FLUAD 2021, QUAD SYR 0.5ML 65+YEAR ADJ (10DOSE/BX)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 35072251586619
Application Flu VaccineFlu VaccineTd VaccineFlu Vaccine, Adjuvanted
Container Type Multiple Dose VialPrefilled SyringeSingle Dose VialPrefilled Syringe
Country of Origin UnknownUnited StatesUnited StatesUnited StatesUnited States
Dosage Form InjectionInjectionInjectionInjection
Generic Drug Code 2083549606
Generic Drug Name Tetanus and Diphtheria Toxoids Adsorbed
NDC Number 70461-0421-1070461-0321-0313533-0131-0170461-0121-03
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 30 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Strength 60 mcg / 0.5 mL60 mcg / 0.5 mL2 Lf - 2 Lf / 0.5 mL45 mcg / 0.5 mL
Type IntramuscularIntramuscularIntramuscularIntramuscular
UNSPSC Code 51201608512016085120162951201608
User Indicated For People 2 Years of Age and AboveIndicated For People 2 Years of Age and Above7 Years of Age and OlderIndicated For People 65 Years of Age and Above
Volume 5 mL0.5 mL0.5 mL0.5 mL
Features and Benefits
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX is approved for use in persons 2 years of age and older
  • FLUCELVAX QUADRIVALENT 5 mL multi-dose vial formulation contains no antibiotics
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2021 - 2022 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains:
  • A/Idaho/07/2018 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Indiana/08/2018 (an A/Kansas/14/2017 (H3N2)-like virus), B/Iowa/06/2017 (a B/Colorado/06/2017-like virus), B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX is approved for use in persons 2 years of age and older
  • FLUCELVAX QUADRIVALENT 0.5 mL pre-filled syringes contain no preservative or antibiotics
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2021 - 2022 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains:
  • A/Idaho/07/2018 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Indiana/08/2018 (an A/Kansas/14/2017 (H3N2)-like virus), B/Iowa/06/2017 (a B/Colorado/06/2017-like virus), B/Singapore/INFTT-16-0610/2016 (a B/Phuket/3073/2013-like virus)
  • Fluad is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUAD is approved for use in persons 65 years of age and older
  • Each 0.5 mL dose contains at least 15 mcg of hemagglutinin (HA) from each of the following three influenza strains recommended for the 2021 - 2022 influenza season; A/Brisbane/02/2018 IVR-190 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Kansas/14/2017 X-327 (an A/Kansas/14/2017 (H3N2)-like virus), B/Maryland/15/2016 (a B/Colorado/06/2017-like virus)
  • FLUAD also contains MF59C.1 adjuvant (MF59®), a squalene based oil-in-water emulsion